Skip to main content
Log in

Role of Metabotropic Glutamate Receptors in the Mechanisms of Experimental Parkinsonism Development

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied the effects of metabotropic glutamate receptor 5 (mGluR5) antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the development of catalepsy and NO generation in the striatum of rats under conditions of long-term treatment with low doses of rotenone, a mitochondrial complex I inhibitor. In rats receiving single intraperitoneal injection of rotenone (1.5 mg/kg), NO concentration in the striatum did not differ from that in animals receiving sunfl ower oil. No signs of catalepsy were observed at these terms in both animal groups. It was demonstrated that long-term rotenone treatment induced catalepsy associated with enhanced NO production in the rat striatum. mGluR5 antagonist MPEP alleviated catalepsy caused by long-term rotenone treatment and prevented rotenone-induced stimulation of NO generation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. V. G. Bashkatova, B. Meldrum, A. Chapman, et al., Neirokhimiya, 18, 258-261 (2001).

    CAS  Google Scholar 

  2. V. D. Mikoyan, L. N. Kubrina, and A. F. Vanin, Biofi zika, 39, 915-918 (1994).

    CAS  Google Scholar 

  3. V. G. Khaindrava, E. A. Kozina, V. S. Kudrin, et al., Byull. Eksp. Biol. Med., 150, No. 11, 494-497 (2010).

    Google Scholar 

  4. V. Bashkatova, M. Alam, A. Vanin, and W. J. Schmidt, Exp. Neurol., 186, No. 2, 235-241 (2004).

    Article  PubMed  CAS  Google Scholar 

  5. R. Betarbet, T. B. Sherer, G. MacKenzie, et al., Nat. Neurosci., 3, No. 12, 1301-1306 (2000).

    Article  PubMed  CAS  Google Scholar 

  6. T. N. Chase, F. Bibbiani, and J. D. Oh, Neurotox. Res., 5, Nos. 1-2, 139-146 (2003).

    Article  PubMed  Google Scholar 

  7. A. Leng, J. Feldon, and B. Ferger, Synapse, 50, No. 3, 240-250 (2003).

    Article  PubMed  CAS  Google Scholar 

  8. F. Nicoletti, J. Bockaert, G. L. Collingridge, et al., Neuropharmacology, 60, Nos. 7-8, 1017-1041 (2011).

    Article  PubMed  CAS  Google Scholar 

  9. J. D. Oh and T. N. Chase, Amino Acids, 23, Nos. 1-3, 133-139 (2002).

    Article  PubMed  CAS  Google Scholar 

  10. J. P. Pin and F. Acher, Current Drug Targets. CNS Neurol. Disord., 1, No. 3, 297-317 (2002).

    Article  CAS  Google Scholar 

  11. T. B. Sherer, R. Betarbet, A. K. Stout, et al., J. Neurosci., 22, 7006-7015 (2002).

    PubMed  CAS  Google Scholar 

  12. D. Sulzer, Trends Neurosci., 30, No. 5, 244-250 (2007).

    Article  PubMed  CAS  Google Scholar 

  13. M. V. Ugrumov, V. G. Khaindrava, E. A. Kozina, et al., Neuroscience, 181, 175-188 (2011).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. G. Bashkatova.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 153, No. 5, pp. 608-610, May, 2012

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bashkatova, V.G., Sudakov, S.K. Role of Metabotropic Glutamate Receptors in the Mechanisms of Experimental Parkinsonism Development. Bull Exp Biol Med 153, 655–657 (2012). https://doi.org/10.1007/s10517-012-1790-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-012-1790-9

Keywords

Navigation